INVESTOR
RELATIONS

BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.

Stock Quotes

NASDAQ: BRTX

News Release

BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100

SEC Filings

Current report pursuant to Section 13 or 15(d)

Corporate Information

BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.

Our advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies’ own regenerative potential to treat major diseases more effectively than current interventions.

Events

No Recent Events

SEC Filings

August 2023